ATE77754T1 - Zusammensetzungen zur behandlung von gehirntumoren. - Google Patents

Zusammensetzungen zur behandlung von gehirntumoren.

Info

Publication number
ATE77754T1
ATE77754T1 AT89301258T AT89301258T ATE77754T1 AT E77754 T1 ATE77754 T1 AT E77754T1 AT 89301258 T AT89301258 T AT 89301258T AT 89301258 T AT89301258 T AT 89301258T AT E77754 T1 ATE77754 T1 AT E77754T1
Authority
AT
Austria
Prior art keywords
drug
migration
administration
compositions
treatment
Prior art date
Application number
AT89301258T
Other languages
English (en)
Inventor
Edward E Luck
Dennis M Brown
Original Assignee
Matrix Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matrix Pharma filed Critical Matrix Pharma
Application granted granted Critical
Publication of ATE77754T1 publication Critical patent/ATE77754T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/475Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fertilizers (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT89301258T 1988-02-11 1989-02-09 Zusammensetzungen zur behandlung von gehirntumoren. ATE77754T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15498488A 1988-02-11 1988-02-11
EP89301258A EP0328389B1 (de) 1988-02-11 1989-02-09 Zusammensetzungen zur Behandlung von Gehirn-Tumoren

Publications (1)

Publication Number Publication Date
ATE77754T1 true ATE77754T1 (de) 1992-07-15

Family

ID=22553654

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89301258T ATE77754T1 (de) 1988-02-11 1989-02-09 Zusammensetzungen zur behandlung von gehirntumoren.

Country Status (7)

Country Link
EP (1) EP0328389B1 (de)
JP (1) JP2862175B2 (de)
AT (1) ATE77754T1 (de)
CA (1) CA1330422C (de)
DE (1) DE68901931T2 (de)
ES (1) ES2045404T3 (de)
GR (1) GR3005841T3 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5626862A (en) 1994-08-02 1997-05-06 Massachusetts Institute Of Technology Controlled local delivery of chemotherapeutic agents for treating solid tumors
US5750146A (en) * 1995-04-28 1998-05-12 Matrix Pharmaceutical, Inc. Translucent collagen formulations with a cytotoxic drug
DE10037983B4 (de) * 2000-08-03 2006-04-13 Stefan Zikeli Polymerzusammensetzung und daraus hergestellter Formkörper mit einem Gehalt an Alkaloid
JP2003119156A (ja) * 2001-08-06 2003-04-23 Kikuji Yamashita コラーゲンを含有する口腔用剤、医薬品および医薬部外品
CN1923281B (zh) * 2005-08-30 2010-05-05 孔庆忠 一种含植物生物碱的抗癌缓释注射剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179753B (en) * 1977-10-13 1982-12-28 Richter Gedeon Vegyeszet Process for producting synergetic pharmaceutical compositions of citostatic activity
US4619913A (en) * 1984-05-29 1986-10-28 Matrix Pharmaceuticals, Inc. Treatments employing drug-containing matrices for introduction into cellular lesion areas

Also Published As

Publication number Publication date
EP0328389B1 (de) 1992-07-01
DE68901931T2 (de) 1992-12-10
DE68901931D1 (de) 1992-08-06
CA1330422C (en) 1994-06-28
GR3005841T3 (de) 1993-06-07
ES2045404T3 (es) 1994-01-16
JP2862175B2 (ja) 1999-02-24
EP0328389A2 (de) 1989-08-16
EP0328389A3 (en) 1989-10-11
JPH021406A (ja) 1990-01-05

Similar Documents

Publication Publication Date Title
KR100334051B1 (ko) 탁산유도체를함유하는항종양조성물
DE69806246T2 (de) Zusammensetzung enthaltend capsaicin oder seine analogen und lokalanästhetika
EP1064000A4 (de) Vitamin d und dessen analoge zur behandlung vom tumoren und anderen hyperproliferativen erkrankungen
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
ATE55258T1 (de) Arzneimittelenthaltende matrizen fuer einfuehrungen in zonen mit cellularen lesionen.
ES2058592T3 (es) El uso de sustancias activas fisiologicamente para la fabricacion de medicamentos para enfermedades cerebrales y neuronales.
DE69533112T2 (de) Verwendung von flavolignanen zur herstellung von medikamenten mit antiproliferativer aktivität in gebärmutter,brust,eierstöcken
ES2167377T3 (es) Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos.
ATE20701T1 (de) Perioperative anwendung der elektronischen schmerzlinderung in verbindung mit anaesthesierenden mitteln.
ATE209908T1 (de) RADIKALFÄNGER (ßSPIN TRAPSß) ZUR BEHANDLUNG VON MIT OXIDATION VON LIPIDEN UND PROTEINEN VERBUNDENEN ERKRANKUNGEN
DK20488A (da) Farmaceutiske praeparater med forlaenget afgivelse
WO2001039762A3 (en) Use of taurolidine or taurultam for the manufacture of a medicament for the treatment of tumors of the central nervous system
DE3851776D1 (de) Verwendung von IGF-II zur Behandlung von Knochenkrankheiten.
RU95106821A (ru) Циклопептиды, способ их получения, фармацевтическая композиция и способ ее получения
ATE202709T1 (de) Zusammensetzungen die g-csf und ein tnf- bindungsprotein enthalten
BR9813318A (pt) Processo de tratamento de tumores e degeneração macular em paciente humano ou veterinário, composição farmacêutica para tratamento de tumores e degeneração macular em um paciente humano ou veterinário
Friedman et al. Chemotherapy of subcutaneous and intracranial human medulloblastoma xenografts in athymic nude mice
ATE392901T1 (de) Mucuna pruriens und extrakte daraus zur behandlung von neurologischen erkrankungen
DE68901931D1 (de) Zusammensetzungen zur behandlung von gehirn-tumoren.
Griffin et al. Preferential action of arsenic trioxide in solid-tumor microenvironment enhances radiation therapy
ATE334589T1 (de) Anti-arrhythmische zusammensetzungen und behandlungsverfahren
AR006202A1 (es) Usos de antagonista ige para preparar un medicamento util para el tratamiento de las enfermedades alergicas y composiciones que los contiene
KR890000108A (ko) 종양 치료용 약제학적 조성물
ATE428438T1 (de) Tcf-ii enthaltende medizinische zusammensetzung
EA200400348A1 (ru) Цисплатиновые составы пониженной токсичности и способы их применения

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee